# Phase 2 Arthritis, Rheumatoid trials recruiting: 34 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 34 trials in phase 2 for Arthritis, Rheumatoid that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Arthritis, Rheumatoid trials: 34 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/arthritis-rheumatoid

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 34
- Recruiting or not yet: 34
- Read on: November 19, 2026

## Trials

The 25 newest of 34, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 29, 2026 | NCT07904754 | Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis | AbbVie | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904754) |
| October 26, 2026 | NCT07895524 | A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004) | Merck Sharp & Dohme LLC | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895524) |
| October 8, 2026 | NCT07864688 | Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid Arthritis | Al-Azhar University | Phase 2 | Not yet recruiting | Rheumatoid Arthritis (RA) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864688) |
| September 1, 2026 | NCT07796516 | Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis | Peking University People's Hospital | Phase 2 | Recruiting | Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796516) |
| August 21, 2026 | NCT07779616 | Study of PTC844 in Participants With Active Rheumatoid Arthritis | PTC Therapeutics | Phase 2 | Recruiting | Rheumatoid Arthritis | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07779616) |
| August 4, 2026 | NCT07745426 | Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis | Tanta University | Phase 2 | Recruiting | Rheumatoid Arthritis (RA) | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745426) |
| July 6, 2026 | NCT07684157 | A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis | Jacobio Pharmaceuticals Co., Ltd. | Phase 2 | Recruiting | Rheumatoid Arthritis (RA) | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684157) |
| June 10, 2026 | NCT07639177 | Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis | Peking Union Medical College Hospital | Phase 2 | Recruiting | Rheumatoid Arthritis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639177) |
| June 8, 2026 | NCT07632872 | Desloratadine as Adjunct Therapy for Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis (RA), Rheumatoid Arthritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632872) |
| June 8, 2026 | NCT07632846 | Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis, Rheumatoid Arthritis (RA) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632846) |
| June 3, 2026 | NCT07624994 | Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine | Centre Jean Perrin | Phase 2 | Not yet recruiting | Digital Osteoarthritis or Rheumatoid Arthritis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624994) |
| June 2, 2026 | NCT07620392 | An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis | Hoffmann-La Roche | Phase 2 | Recruiting | Rheumatoid Arthritis | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620392) |
| May 5, 2026 | NCT07566351 | Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07566351) |
| April 16, 2026 | NCT07534332 | Disulfiram in Rheumatoid Arthritis | University of Oklahoma | Phase 2 | Not yet recruiting | Rheumatoid Arthritis, Inflammation, Obesity | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07534332) |
| March 27, 2026 | NCT07497282 | Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis | Ain Shams University | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497282) |
| February 20, 2026 | NCT07423533 | Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who... | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 2 | Recruiting | Rheumatoid Arthritis | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07423533) |
| February 12, 2026 | NCT07408024 | Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis | Toll Biotech Co. Ltd. (Beijing) | Phase 2 | Recruiting | Rheumatoid Arthritis (RA) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408024) |
| January 30, 2026 | NCT07377773 | QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis | Qilu Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Rheumatoid Arthritis (RA) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07377773) |
| December 11, 2025 | NCT07276581 | A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | AstraZeneca | Phase 2 | Recruiting | Rheumatoid Arthritis | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276581) |
| August 24, 2025 | NCT07138898 | Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty | NYU Langone Health | Phase 2 | Recruiting | Rheumatic Disease | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07138898) |
| August 22, 2025 | NCT07137598 | A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded... | Hoffmann-La Roche | Phase 2 | Recruiting | Rheumatoid Arthritis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07137598) |
| June 10, 2025 | NCT07013110 | An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Rheumatoid Arthritis (RA), Rheumatology | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013110) |
| June 4, 2025 | NCT07004725 | Therapy of Niacin for Rheumatoid Arthritis | Peking University People's Hospital | Phase 2 | Not yet recruiting | Rheumatoid Arthritis (RA) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07004725) |
| May 31, 2025 | NCT06998628 | Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis | Tanta University | Phase 2 | Recruiting | Rheumatoid Arthritis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06998628) |
| May 25, 2025 | NCT06991114 | AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing... | Artiva Biotherapeutics, Inc. | Phase 2 | Recruiting | Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06991114) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Horus University | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 2 |
| Tanta University | 2 |
| Peking University People's Hospital | 2 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 2 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 1 |
| Toll Biotech Co. Ltd. (Beijing) | 1 |
| [PTC Therapeutics](https://specstream.ai/data/clinical-trials/company/ptc-therapeutics) | 1 |
| [Changchun GeneScience Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/changchun-genescience-pharmaceutical-co-ltd) | 1 |
| Centre Jean Perrin | 1 |
| Artiva Biotherapeutics, Inc. | 1 |
| German University in Cairo | 1 |
| Odense University Hospital | 1 |
| University Medical Center Groningen | 1 |
| SynAct Pharma Aps | 1 |
| University of Oklahoma | 1 |
| Jacobio Pharmaceuticals Co., Ltd. | 1 |
| VA Office of Research and Development | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Ain Shams University | 1 |
| Al-Azhar University | 1 |
| XBiotech, Inc. | 1 |
| NYU Langone Health | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 11 |
| Egypt | 7 |
| China | 6 |
| Poland | 6 |
| Spain | 6 |
| Germany | 5 |
| Brazil | 4 |
| France | 4 |
| Argentina | 3 |
| Bulgaria | 3 |
| Canada | 3 |
| United Kingdom | 3 |
| Italy | 3 |
| Denmark | 3 |
| Hungary | 2 |
| Mexico | 2 |
| Puerto Rico | 2 |
| South Africa | 2 |
| Belgium | 2 |
| Portugal | 2 |
| Serbia | 2 |
| Chile | 1 |
| Japan | 1 |
| Ukraine | 1 |
| Australia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Plastics companies in the United States](https://specstream.ai/data/businesses/plastics-companies/united-states)
- [Recycling centers in the United States](https://specstream.ai/data/businesses/recycling-centers/united-states)
- [South African restaurants in the United States](https://specstream.ai/data/businesses/south-african-restaurants/united-states)
- [Tires manufacturers in the United States](https://specstream.ai/data/businesses/tires-manufacturers/united-states)
- [Waterproofing contractors in the United States](https://specstream.ai/data/businesses/waterproofing-contractors/united-states)
- [Appliance manufacturers in the United States](https://specstream.ai/data/businesses/appliance-manufacturers/united-states)
